Saltar al contenido
Merck

Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides.

STAR protocols (2021-06-15)
Demetra S M Chatzileontiadou, Christopher Szeto, Dhilshan Jayasinghe, Stephanie Gras
RESUMEN

Understanding T-cell responses requires identifying viral peptides presented by human leukocyte antigens (HLAs). X-ray crystallography can be used to visualize their presentation. This protocol describes the expression, purification, and crystallization of HLA-A∗02:01, one of the most frequent HLA in the global population in complex with peptides derived from the SARS-CoV-2 nucleocapsid protein. This protocol can be applied to different HLA class I molecules bound to other peptides. For complete details on the use and execution of this protocol, please refer to Szeto et al. (2021).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ácido etilenodiaminotetraacético disodium salt dihydrate, suitable for electrophoresis, for molecular biology, 99.0-101.0% (titration)
Sigma-Aldrich
Poli(etilenglicol), BioUltra, 3,350
Sigma-Aldrich
Bromophenol Blue, titration: suitable
Sigma-Aldrich
L-arginina monohydrochloride, reagent grade, ≥98% (HPLC), powder